Cardiovascular Biorepository: Using patient and donor samples to study heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational repository that stores and analyzes biospecimens from patients undergoing cardiovascular procedures at the University of Kentucky. The aim is to explore molecular, cellular, and tissue-level changes related to cardiovascular disease and therapies. It is a prospective collection effort, focusing on sample quality, documentation, and linkage to clinical data. No interventions are performed as part of the study; it supports future translational research by providing well-characterized biospecimens. The lead sponsor is Kenneth S. Campbell, with samples collected at the University of Kentucky's Division of Cardiovascular Medicine.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients undergoing cardiovascular surgery/procedure at the University of Kentucky who are at least 18 years of age, and organ donors of any age.

Where it's running

• University of Kentucky, Department of Internal Medicine, Division of Cardiovascular Medicine
  Lexington, Kentucky, United States Recruiting

Study contacts

• Principal investigator: Kenneth S Campbell, PhD — University of Kentucky
• Study coordinator: Kenneth S Campbell, PhD
• Email: k.s.campbell@uky.edu
• Phone: (859) 323-8157

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.